175 related articles for article (PubMed ID: 15793309)
1. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice.
Bubikat A; De Windt LJ; Zetsche B; Fabritz L; Sickler H; Eckardt D; Gödecke A; Baba HA; Kuhn M
J Biol Chem; 2005 Jun; 280(22):21594-9. PubMed ID: 15793309
[TBL] [Abstract][Full Text] [Related]
2. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle.
Jankowski M; Wang D; Mukaddam-Daher S; Gutkowska J
J Endocrinol; 2005 Jan; 184(1):209-17. PubMed ID: 15642797
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
5. Modulation of mouse cardiac function in vivo by eNOS and ANP.
Gyurko R; Kuhlencordt P; Fishman MC; Huang PL
Am J Physiol Heart Circ Physiol; 2000 Mar; 278(3):H971-81. PubMed ID: 10710367
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
[TBL] [Abstract][Full Text] [Related]
7. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
8. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor.
Sabrane K; Gambaryan S; Brandes RP; Holtwick R; Voss M; Kuhn M
J Biol Chem; 2003 May; 278(20):17963-8. PubMed ID: 12637561
[TBL] [Abstract][Full Text] [Related]
10. Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1.
Sabrane K; Kruse MN; Gazinski A; Kuhn M
Endocrinology; 2009 May; 150(5):2382-7. PubMed ID: 19179430
[TBL] [Abstract][Full Text] [Related]
11. A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptide.
Klaiber M; Dankworth B; Kruse M; Hartmann M; Nikolaev VO; Yang RB; Völker K; Gassner B; Oberwinkler H; Feil R; Freichel M; Groschner K; Skryabin BV; Frantz S; Birnbaumer L; Pongs O; Kuhn M
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18500-5. PubMed ID: 22027011
[TBL] [Abstract][Full Text] [Related]
12. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
[TBL] [Abstract][Full Text] [Related]
13. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
Kilic A; Velic A; De Windt LJ; Fabritz L; Voss M; Mitko D; Zwiener M; Baba HA; van Eickels M; Schlatter E; Kuhn M
Circulation; 2005 Oct; 112(15):2307-17. PubMed ID: 16216978
[TBL] [Abstract][Full Text] [Related]
14. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression.
Flaherty MP; Brown M; Grupp IL; Schultz JE; Murphree SS; Jones WK
Cardiovasc Toxicol; 2007; 7(3):165-77. PubMed ID: 17901560
[TBL] [Abstract][Full Text] [Related]
15. Heart-Microcirculation Connection: Effects of ANP (Atrial Natriuretic Peptide) on Pericytes Participate in the Acute and Chronic Regulation of Arterial Blood Pressure.
Špiranec Spes K; Chen W; Krebes L; Völker K; Abeßer M; Eder Negrin P; Cellini A; Nickel A; Nikolaev VO; Hofmann F; Schuh K; Schweda F; Kuhn M
Hypertension; 2020 Nov; 76(5):1637-1648. PubMed ID: 32951468
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats.
Costa MA; Elesgaray R; Caniffi C; Fellet A; Mac Laughlin M; Arranz C
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H778-86. PubMed ID: 19783776
[TBL] [Abstract][Full Text] [Related]
17. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
18. Osmoregulation of endothelial nitric-oxide synthase gene expression in inner medullary collecting duct cells. Role in activation of the type A natriuretic peptide receptor.
Chen S; Cao L; Intengan HD; Humphreys M; Gardner DG
J Biol Chem; 2002 Sep; 277(36):32498-504. PubMed ID: 12082097
[TBL] [Abstract][Full Text] [Related]
19. Neuronal and endothelial nitric oxide synthase gene knockout mice.
Huang PL
Braz J Med Biol Res; 1999 Nov; 32(11):1353-9. PubMed ID: 10559836
[TBL] [Abstract][Full Text] [Related]
20. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
Kishimoto I; Rossi K; Garbers DL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
